Citadel Advisors’s Aravive, Inc. Common Stock ARAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,400
Closed -$977 15545
2023
Q3
$977 Sell
7,400
-26,700
-78% -$16.8K ﹤0.01% 13940
2023
Q2
$43K Sell
34,100
-54,000
-61% -$87.6K ﹤0.01% 11985
2023
Q1
$176K Sell
88,100
-3,300
-4% -$6.2K ﹤0.01% 10386
2022
Q4
$121K Buy
+91,400
New +$117K ﹤0.01% 10950
2022
Q1
Sell
-14,000
Closed -$31K 14880
2021
Q4
$31K Sell
14,000
-40,100
-74% -$133K ﹤0.01% 13473
2021
Q3
$201K Sell
54,100
-83,600
-61% -$357K ﹤0.01% 11976
2021
Q2
$823K Buy
137,700
+125,800
+1,057% +$665K ﹤0.01% 8874
2021
Q1
$78K Sell
11,900
-6,100
-34% -$40.1K ﹤0.01% 12662
2020
Q4
$102K Sell
18,000
-1,300
-7% -$7.13K ﹤0.01% 10213
2020
Q3
$91K Buy
+19,300
New +$137K ﹤0.01% 9328
2020
Q1
Sell
-27,500
Closed -$376K 10361
2019
Q4
$376K Buy
+27,500
New +$243K ﹤0.01% 7248
2018
Q4
Sell
-1,800
Closed -$15K 9914
2018
Q3
$15K Sell
1,800
-183
-9% -$1.93K ﹤0.01% 9069
2018
Q2
$24K Buy
+1,983
New +$20.4K ﹤0.01% 8610
2018
Q1
Sell
-3,450
Closed -$46K 8928
2017
Q4
$46K Sell
3,450
-9,150
-73% -$118K ﹤0.01% 7654
2017
Q3
$185K Buy
+12,600
New +$1.27M ﹤0.01% 6754

Other funds holding ARAV

Citadel Advisors's ARAV Position: Q3 2023 in Review

Citadel Advisors sold out of Aravive, Inc. Common Stock (ARAV) in Q3 2023, closing a stake of 107,555 shares — an estimated $67.6K sold.

Citadel Advisors first reported a position in ARAV in Q1 2014 and held it in 21 quarters. The position peaked at $3.94M in Q3 2015. 33 funds tracked by Wall St. Rank hold ARAV as of Q3 2023.

  • Citadel Advisors reported no remaining Aravive, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Citadel Advisors sold 107,555 Aravive, Inc. Common Stock shares in Q3 2023, an estimated $67.6K.
  • Citadel Advisors first reported a position in Aravive, Inc. Common Stock in Q1 2014 and held it in 21 quarters.
  • Citadel Advisors's Aravive, Inc. Common Stock position peaked at $3.94M in Q3 2015.
  • 33 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.